Tuesday, August 14, 2007
FDA Alleges False Advertising By Pfizer
CNN reports that the FDA has charged Pfizer with false advertising for its anti-schizophrenia drug Geodon. The FDA alleges that a medical journal advertisement by Pfizer is "is false or misleading because it omits important risk information and contains unsubstantiated superiority claims." The FDA issued a warning letter to Pfizer back in July, and just posted the letter on its website yesterday.